Showing 1591-1600 of 5689 results for "".
A (Very) Brief History of IOLs
https://modernod.com/topics/cataractrefractive-surgery/a-very-brief-history-of-iols/39145/Premium implant technologies can address a range of issues, with increasing emphasis on customization.MIGS: A Crash Course
https://modernod.com/topics/glaucoma/migs-a-crash-course/39144/An introduction to a blossoming component of eye care.Three Things About Uveitis That All ODs Must Know
https://modernod.com/topics/retina/three-things-about-uveitis-that-all-ods-must-know/39141/A primer in uveitis.Keratoconus and Possible Treatments
https://modernod.com/topics/corneaanterior-segment/keratoconus-and-possible-treatments/39139/The prognosis is good if the condition is treated in a timely manner.Lessons from the PHACO Study
https://modernod.com/topics/cataractrefractive-surgery/lessons-from-the-phaco-study/39138/A pristine ocular surface helps ensure postoperative satisfaction.Where Optometry Is Going: A Roundtable
https://modernod.com/topics/cataractrefractive-surgery/where-are-you-going-where-have-you-been/39137/An OD roundtable on optometry’s evolution.Be Ready When Asked, “What’s Your Specialty?”
https://modernod.com/topics/cataractrefractive-surgery/be-ready-when-asked-whats-your-specialty/39134/Trying to attract the attention of an ophthalmic practice? Specialization and passion top the list of attractive qualities.The Optometric Role in Cataract Surgery
https://modernod.com/topics/cataractrefractive-surgery/the-optometric-role-in-cataract-surgery/39133/Take charge of the surgical encounter in order to ensure that your patient stays happy.Glaukos' MIGS Technology Certified in Europe; New Phase 3 Data for Presbyopia Drop
https://modernod.com/podcasts/eyewire-news-the-podcast/glaukos-migs-technology-certified-in-europe-new-phase-3-data-for-presbyopia-drop/37091/Glaukos receives European Union certification for several of its MIGS technologies; Opus Genetics and Viatris present phase 3 results for their investigational presbyopia eye drop; and J&J launches the first and only daily disposable contact lens for people with both astigmatism and presbyopia.2024 Year in Review — Part 1
https://modernod.com/podcasts/eyewire-news-the-podcast/2024-year-in-review-part-1/37064/In today’s broadcast, we look back at the top stories from the first half of 2024. There were several advancements made during the first six months., including the approval of an excimer laser platform; the global adoption of sustained-released anti-VEGF treatments for retinal diseases; the rollout